Study identifies potential epigenetic target for pancreatic cancer
Researchers at University of Texas M. D. Anderson Cancer Center (Houston, TX, United States) have identified arginine methyltransferase 1 as a potential therapeutic target for pancreatic ductal adenocarcinoma.
Please sign in or register for FREE to view this content
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.